#PFS
👏🏼Interesting study #SBRT+/-#LuPSMA @ascocancer.bsky.social

⭐️Innovative design w/limited dosing of LuPSMA #oligorecurrent #ProstateCancer

❓What if all pts were MTD-Naive

🤔important differences in 🔑baseline characteristics favor combo

🤔PFS criteria w/❓clinical value

ascopubs.org/doi/pdf/10.1...
November 14, 2025 at 1:53 AM
So far pathfinder society has been disappointing. It seems to be mostly just mechanical. “I roll diplomacy,” “I roll occultism.” No description of what characters are actually saying or doing.

It’s Roll Playing not Role Playing.

#pf2e #ttrpg #pfs #pathfinder
November 14, 2025 at 1:36 AM
Two quick PFs on RJ Barrett and he sits down less than 4 minutes into the game
November 14, 2025 at 12:19 AM
Great to see another study w high efficacy of low-dose nivolumab (40mg Q2W; plus lenalidomide) in relapsed Hodgkin lymphoma: 90% ORR (60% CR, 30% PR), promising PFS & saturated PD1 receptor occupancy. Do we really need 240mg Q2W? www.sciencedirect.com/science/arti... @bloodjournals.hematology.org
November 13, 2025 at 8:36 PM
Oh of course! I wasn't trying to say "join a clear party right away", I was just using it as part of the example for my own usual experiences with how PFs tend to go in certain types of parties- sorry for any potential confusion due to weird wording! ^^'
November 13, 2025 at 5:33 PM
High pSTAT3 in reactive astrocytes is linked to higher intracranial recurrence and shorter PFS in triple-negative #BreastCancer #BrainMetastases. STAT3 emerges as a potential prognostic biomarker and therapeutic target.

📖 Read the full article: pubmed.ncbi.nlm.nih.gov/40795951/
STAT3 expression in brain metastases from breast cancer is correlated with molecular subtype and impacts clinical outcome - PubMed
This study indicates that STAT3 expression prevails in reactive astrocytes surrounding triple-negative BrM in comparison to HER2-positive and luminal BrM, and these findings mirror those observed in…
pubmed.ncbi.nlm.nih.gov
November 13, 2025 at 1:24 PM
PFS' Carla Brown: 'We've built a stronger, more constructive relationship with the CII'

incm.pub/3JTCK6H
PFS' Carla Brown: 'We've built a stronger, more constructive relationship with the CII'
The Personal Finance Society (PFS) has worked to improve on its relationship with the Chartered Insurance Institute (CII), its president Carla Brown told delegates.
incm.pub
November 13, 2025 at 12:58 PM
📊 Key Findings:
• Higher substantial tumor ADC (sADC) → longer overall survival (HR 0.63, p = 0.015)
• Positive ΔsADC group → better PFS (12 vs 6.4 mo) & OS (20.5 vs 13.3 mo, p < 0.001)
• sADC links tumor burden ↔ inflammation
Mediation and prognostic value of apparent diffusion coefficient in HCC patients receiving immune checkpoint inhibitors - Insights into Imaging
Objectives The study investigated the potential association between tumor size and inflammation from the standpoint of apparent diffusion coefficient (ADC) and the prognostic significance of ADC in…
insightsimaging.springeropen.com
November 13, 2025 at 10:00 AM
進行扁平上皮NSCLCの1次治療、ivonescimab併用がICI併用と比較しPFS改善(HARMONi-6)/Lancet|CareNet.com - CareNet.com
news.google.com/rss/articles/CBMiX0FVX3lxTE5IdVR1dTRIQjc3OUZ6cG4tejdBV1pUYkJZZGMtSVNlZzdHbDBmZ0hSbmhiMlk0bDBoMzdZanFrU2dvd2F3YmFoaVYwQlVNa0JHQ0JlUVhZVjFtcWVTV2hr?oc=5
November 13, 2025 at 9:09 AM
PFS National Conference gets under way in London

https://www.europesays.com/uk/567219/

PFS Annual Conference 2025 The Personal Finance Society’s annual National Conference – the biggest annual gathering of Financial…#uk #news #uknews
PFS National Conference gets under way in London - United Kingdom
PFS Annual Conference 2025
www.europesays.com
November 13, 2025 at 8:30 AM
#phosh's file selector (`pfs`) picked up existing 👍-nails of files since some time but didn't create missing ones. @arunmanij fixed that by creating a thumbnailing service. The file chooser calls into this service to request the creation of the missing thumbnails.

Having things in an extra […]
[Video] Original post on social.phosh.mobi
social.phosh.mobi
November 13, 2025 at 8:15 AM
進行扁平上皮NSCLCの1次治療、ivonescimab併用がICI併用と比較しPFS改善(HARMONi-6)/Lancet|CareNet.com - CareNet.com
news.google.com/rss/articles/CBMiX0FVX3lxTE5IdVR1dTRIQjc3OUZ6cG4tejdBV1pUYkJZZGMtSVNlZzdHbDBmZ0hSbmhiMlk0bDBoMzdZanFrU2dvd2F3YmFoaVYwQlVNa0JHQ0JlUVhZVjFtcWVTV2hr?oc=5
November 13, 2025 at 8:09 AM
進行扁平上皮NSCLCの1次治療、ivonescimab併用がICI併用と比較しPFS改善(HARMONi-6)/Lancet|CareNet.com - CareNet.com
news.google.com/rss/articles/CBMiX0FVX3lxTE5IdVR1dTRIQjc3OUZ6cG4tejdBV1pUYkJZZGMtSVNlZzdHbDBmZ0hSbmhiMlk0bDBoMzdZanFrU2dvd2F3YmFoaVYwQlVNa0JHQ0JlUVhZVjFtcWVTV2hr?oc=5
November 13, 2025 at 7:09 AM
進行扁平上皮NSCLCの1次治療、ivonescimab併用がICI併用と比較しPFS改善(HARMONi-6)/Lancet|CareNet.com - CareNet.com
news.google.com/rss/articles/CBMiX0FVX3lxTE5IdVR1dTRIQjc3OUZ6cG4tejdBV1pUYkJZZGMtSVNlZzdHbDBmZ0hSbmhiMlk0bDBoMzdZanFrU2dvd2F3YmFoaVYwQlVNa0JHQ0JlUVhZVjFtcWVTV2hr?oc=5
November 13, 2025 at 6:09 AM
進行扁平上皮NSCLCの1次治療、ivonescimab併用がICI併用と比較しPFS改善(HARMONi-6)/Lancet|CareNet.com - CareNet.com
news.google.com/rss/articles/CBMiX0FVX3lxTE5IdVR1dTRIQjc3OUZ6cG4tejdBV1pUYkJZZGMtSVNlZzdHbDBmZ0hSbmhiMlk0bDBoMzdZanFrU2dvd2F3YmFoaVYwQlVNa0JHQ0JlUVhZVjFtcWVTV2hr?oc=5
November 13, 2025 at 5:09 AM
進行扁平上皮NSCLCの1次治療、ivonescimab併用がICI併用と比較しPFS改善(HARMONi-6)/Lancet|CareNet.com - CareNet.com
news.google.com/rss/articles/CBMiX0FVX3lxTE5IdVR1dTRIQjc3OUZ6cG4tejdBV1pUYkJZZGMtSVNlZzdHbDBmZ0hSbmhiMlk0bDBoMzdZanFrU2dvd2F3YmFoaVYwQlVNa0JHQ0JlUVhZVjFtcWVTV2hr?oc=5
November 13, 2025 at 4:09 AM
進行扁平上皮NSCLCの1次治療、ivonescimab併用がICI併用と比較しPFS改善(HARMONi-6)/Lancet|CareNet.com - CareNet.com
news.google.com/rss/articles/CBMiX0FVX3lxTE5IdVR1dTRIQjc3OUZ6cG4tejdBV1pUYkJZZGMtSVNlZzdHbDBmZ0hSbmhiMlk0bDBoMzdZanFrU2dvd2F3YmFoaVYwQlVNa0JHQ0JlUVhZVjFtcWVTV2hr?oc=5
November 13, 2025 at 3:09 AM
進行扁平上皮NSCLCの1次治療、ivonescimab併用がICI併用と比較しPFS改善(HARMONi-6)/Lancet|CareNet.com - CareNet.com
news.google.com/rss/articles/CBMiX0FVX3lxTE5IdVR1dTRIQjc3OUZ6cG4tejdBV1pUYkJZZGMtSVNlZzdHbDBmZ0hSbmhiMlk0bDBoMzdZanFrU2dvd2F3YmFoaVYwQlVNa0JHQ0JlUVhZVjFtcWVTV2hr?oc=5
November 13, 2025 at 2:09 AM
進行扁平上皮NSCLCの1次治療、ivonescimab併用がICI併用と比較しPFS改善(HARMONi-6)/Lancet|CareNet.com - CareNet.com
news.google.com/rss/articles/CBMiX0FVX3lxTE5IdVR1dTRIQjc3OUZ6cG4tejdBV1pUYkJZZGMtSVNlZzdHbDBmZ0hSbmhiMlk0bDBoMzdZanFrU2dvd2F3YmFoaVYwQlVNa0JHQ0JlUVhZVjFtcWVTV2hr?oc=5
November 13, 2025 at 1:09 AM
【ブログ更新】
進行扁平上皮NSCLCと闘うあなたへ:1次治療に新たな希望の光「ivonescimab」がICI併用を上回るPFS改善!【HARMONi-6試験速報】

#肺がん治療 #NSCLC #新薬情報 #がん患者 https://kenko-mosunon.blogspot.com/2025/11/nsclc1ivonescimabicipfsharmoni-6.html
November 13, 2025 at 1:05 AM
進行扁平上皮NSCLCの1次治療、ivonescimab併用がICI併用と比較しPFS改善(HARMONi-6)/Lancet|CareNet.com - CareNet.com
news.google.com/rss/articles/CBMiX0FVX3lxTE5IdVR1dTRIQjc3OUZ6cG4tejdBV1pUYkJZZGMtSVNlZzdHbDBmZ0hSbmhiMlk0bDBoMzdZanFrU2dvd2F3YmFoaVYwQlVNa0JHQ0JlUVhZVjFtcWVTV2hr?oc=5
November 13, 2025 at 12:09 AM
進行扁平上皮NSCLCの1次治療、ivonescimab併用がICI併用と比較しPFS改善(HARMONi-6)/Lancet|CareNet.com - CareNet.com
news.google.com/rss/articles/CBMiX0FVX3lxTE5IdVR1dTRIQjc3OUZ6cG4tejdBV1pUYkJZZGMtSVNlZzdHbDBmZ0hSbmhiMlk0bDBoMzdZanFrU2dvd2F3YmFoaVYwQlVNa0JHQ0JlUVhZVjFtcWVTV2hr?oc=5
November 12, 2025 at 11:09 PM
Section Leader - EXPPFS - 5415 Blackford Bridge PFS Job educativ.net/jobs/job/48540...
November 12, 2025 at 9:26 PM
Pembrolizumab + weekly paclitaxel ± bevacizumab in pts with platinum-resistant ovarian cancer led to improved PFS, OS in overall, PD-L1 CPS ≥ 1 populations ovariancancer
🗣️From ESMO25
👩‍⚕️Presenter Nicoletta Colombo, MD, PhD; Discussant
https://ow.ly/FgHC50XqFJc
November 12, 2025 at 8:01 PM